fbpx

Join a Paid COVID-19 Research Study

ProSciento is looking for unvaccinated adults to take part in a paid COVID-19 clinical research study in San Diego, California.

You will earn financial payment up to $1,775 if all study visits are completed. All study visits will be at our pristine and cutting-edge clinical research center in sunny San Diego, California. Added travel reimbursements are also available for people who do not live in the greater San Diego, California area.

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling research studies at our research center.

Benefits of study participation will vary, but you will be compensated for your time and involvement in the advancement of science and medicine for COVID-19 patients. Study evaluations are managed by our passionate team of doctors and your test results will be free of cost to you. Health insurance is not needed to participate.

We are happy to answer any questions you may have, and we will provide all details about the study during your phone call with our caring and highly trained healthcare team.

We are exploring whether a new non-injectable COVID-19 study medication is safe and effective when given to patients via nasal drops. This study medication will not produce an active COVID-19 infection and the study medication does not contain an active virus.

The study medication may act as an alternative to traditional vaccinations now available in the market. Your participation and contribution to science may prevent the spread and exposure of COVID-19 of moderate to severe stages of the infection in COVID-19 patients.

By taking part you can help alleviate the current treatment shortage in the United States and make other COVID-19 treatment alternatives and formulas more accessible to the public.

You may qualify if you are:

  • At least 18 years old
  • Are a healthy adult
  • Have not had a prior COVID-19 infection
  • Have not have a prior COVID-19 vaccination

SO174-5405-DRPCOV1